Cardio Diagnostics Holdings, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CDIO Nasdaq 2836 cdio.ai

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India - Jan 7th, 2026 4:25 am
Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community - Jan 6th, 2026 6:35 am
Is DXC (DXC) Centralizing Digital And AI Leadership To Reframe Its Long-Term Competitiveness Story? - Dec 10th, 2025 6:05 pm
DXC Appoints Russell Jukes as Chief Digital Information Officer to Strengthen Unified Digital Strategy - Dec 8th, 2025 7:00 am
Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Dec 3rd, 2025 6:35 am
Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD’s Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions - Nov 5th, 2025 6:35 am
Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community - Oct 28th, 2025 6:35 am
Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States - Oct 21st, 2025 6:35 am
e.l.f. Beauty’s CDIO says she’s responsible for AI’s foundation, but that these tools aren’t an IT mandate - Sep 10th, 2025 8:45 am
Cardio Diagnostics Holdings Second Quarter 2025 Earnings: US$0.97 loss per share (vs US$1.71 loss in 2Q 2024) - Aug 16th, 2025 7:40 am
Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS) - Jul 22nd, 2025 6:31 am
Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease - Jul 8th, 2025 6:31 am
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology - Jun 10th, 2025 6:35 am
Cardio Diagnostics Holdings, Inc. (CDIO): A Bull Case Theory - Jun 9th, 2025 7:43 am
Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price - May 29th, 2025 6:35 am
Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico - May 20th, 2025 6:35 am
Cardio Diagnostics Holdings First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - May 17th, 2025 7:06 am
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split - May 8th, 2025 6:35 am
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session - Mar 26th, 2025 6:31 am
Cardio Diagnostics Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Mar 22nd, 2025 8:33 am